Australia markets open in 8 hours 25 minutes

ImpediMed Limited (IPD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0910-0.0020 (-2.15%)
At close: 04:10PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 165.84M
Enterprise value 125.28M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)14.88
Price/book (mrq)3.25
Enterprise value/revenue 11.94
Enterprise value/EBITDA -6.68

Trading information

Stock price history

Beta (5Y monthly) 3.02
52-week change 3-46.47%
S&P500 52-week change 3-13.20%
52-week high 30.2050
52-week low 30.0490
50-day moving average 30.0799
200-day moving average 30.0927

Share statistics

Avg vol (3-month) 31.32M
Avg vol (10-day) 3768.86k
Shares outstanding 51.78B
Implied shares outstanding 6N/A
Float 81.55B
% held by insiders 113.67%
% held by institutions 119.94%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022


Profit margin -188.09%
Operating margin (ttm)-200.32%

Management effectiveness

Return on assets (ttm)-28.48%
Return on equity (ttm)-51.92%

Income statement

Revenue (ttm)10.57M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)9.16M
EBITDA -20.23M
Net income avi to common (ttm)-19.87M
Diluted EPS (ttm)-0.0130
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)40.73M
Total cash per share (mrq)0.02
Total debt (mrq)170k
Total debt/equity (mrq)0.33
Current ratio (mrq)6.44
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-15.66M
Levered free cash flow (ttm)-13.43M